Some patients using semaglutide have reported allergy-like symptoms such as nasal congestion, sneezing, and even respiratory discomfort
New GLP-1 science and drugs reach tipping point, reshaping health and nutrition Emerging science and drug product development are poised to transform the US GLP-1 landscape, potentially increasing the adoption of these medications even further
It belongs to a class called GLP-1 receptor agonists
Tirzepatide 15 mg (Zepbound) produced 20.9% at 72 weeks in SURMOUNT-1 (N=2,539) 15
At Buffalo Weight Loss , we understand that weight loss can be challenging, especially when diet and exercise alone arent helping you reach your goals
Common side effects The biggest risk for side effects is when you first start the medication and when you increase your dose